Jo Y, Sim H, Yun B, Park Y, Jin H
Exp Mol Med. 2024; 56(10):2113-2126.
PMID: 39349829
PMC: 11541569.
DOI: 10.1038/s12276-024-01317-9.
Chasov V, Zmievskaya E, Ganeeva I, Gilyazova E, Davletshin D, Filimonova M
J Biomed Res. 2024; :1-16.
PMID: 38828853
PMC: 11629155.
DOI: 10.7555/JBR.38.20240009.
Bretscher P
Cancers (Basel). 2024; 16(7).
PMID: 38611110
PMC: 11010850.
DOI: 10.3390/cancers16071431.
Dasgupta S, Gayen S, Chakraborty T, Afrose N, Pal R, Mahata S
Med Oncol. 2024; 41(5):98.
PMID: 38536512
DOI: 10.1007/s12032-024-02337-1.
Kufera J, Armstrong C, Wu F, Singhal A, Zhang H, Lai J
J Exp Med. 2024; 221(3).
PMID: 38270554
PMC: 10818065.
DOI: 10.1084/jem.20231511.
Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies.
Harris C, Cohen S
BioDrugs. 2024; 38(2):205-226.
PMID: 38261155
PMC: 10912315.
DOI: 10.1007/s40259-023-00641-2.
Lymph node macrophages drive innate immune responses to enhance the anti-tumor efficacy of mRNA vaccines.
Kubara K, Yamazaki K, Miyazaki T, Kondo K, Kurotaki D, Tamura T
Mol Ther. 2024; 32(3):704-721.
PMID: 38243602
PMC: 10928146.
DOI: 10.1016/j.ymthe.2024.01.020.
Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions.
Yang L, Zhuang L, Ye Z, Li L, Guan J, Gong W
iScience. 2023; 26(10):107881.
PMID: 37841590
PMC: 10570004.
DOI: 10.1016/j.isci.2023.107881.
Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy.
Park J, Gazzaniga F, Kasper D, Sharpe A
Exp Mol Med. 2023; 55(9):1913-1921.
PMID: 37696895
PMC: 10545783.
DOI: 10.1038/s12276-023-01075-0.
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties.
Elsayed A, Pellegrino C, Pluss L, Peissert F, Benz R, Ulrich F
MAbs. 2023; 15(1):2220839.
PMID: 37288872
PMC: 10251795.
DOI: 10.1080/19420862.2023.2220839.
The PPARα Regulation of the Gut Physiology in Regard to Interaction with Microbiota, Intestinal Immunity, Metabolism, and Permeability.
Grabacka M, Plonka P, Pierzchalska M
Int J Mol Sci. 2022; 23(22).
PMID: 36430628
PMC: 9696208.
DOI: 10.3390/ijms232214156.
Adenoviral delivery of soluble ovine OX40L or CD70 costimulatory molecules improves adaptive immune responses to a model antigen in sheep.
Rojas J, Mancho C, Louloudes-Lazaro A, Rodriguez-Martin D, Avia M, Moreno S
Front Cell Infect Microbiol. 2022; 12:1010873.
PMID: 36211974
PMC: 9538494.
DOI: 10.3389/fcimb.2022.1010873.
Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System.
Meraviglia-Crivelli D, Zheleva A, Barainka M, Moreno B, Villanueva H, Pastor F
Biomedicines. 2022; 10(8).
PMID: 36009389
PMC: 9405394.
DOI: 10.3390/biomedicines10081842.
Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity.
Richardson N, Wraith D
Immunother Adv. 2022; 1(1):ltab009.
PMID: 35919740
PMC: 9327121.
DOI: 10.1093/immadv/ltab009.
The perception and response of T cells to a changing environment are based on the law of initial value.
Huseby E, Teixeiro E
Sci Signal. 2022; 15(736):eabj9842.
PMID: 35639856
PMC: 9290192.
DOI: 10.1126/scisignal.abj9842.
The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers.
Biggi A, Elgui De Oliveira D
Biomolecules. 2022; 12(3).
PMID: 35327589
PMC: 8946074.
DOI: 10.3390/biom12030397.
Mesenchymal Stem Cell-Immune Cell Interaction and Related Modulations for Bone Tissue Engineering.
Chen R, Hao Z, Wang Y, Zhu H, Hu Y, Chen T
Stem Cells Int. 2022; 2022:7153584.
PMID: 35154331
PMC: 8825274.
DOI: 10.1155/2022/7153584.
Leveraging self-assembled nanobiomaterials for improved cancer immunotherapy.
Vincent M, Navidzadeh J, Bobbala S, Scott E
Cancer Cell. 2022; 40(3):255-276.
PMID: 35148814
PMC: 8930620.
DOI: 10.1016/j.ccell.2022.01.006.
Immune checkpoint inhibitors for the treatment of melanoma.
Sabbatino F, Liguori L, Pepe S, Ferrone S
Expert Opin Biol Ther. 2022; 22(5):563-576.
PMID: 35130816
PMC: 9038682.
DOI: 10.1080/14712598.2022.2038132.
Senescence-induced changes in CD4 T cell differentiation can be alleviated by treatment with senolytics.
Lorenzo E, Torrance B, Keilich S, Al-Naggar I, Harrison A, Xu M
Aging Cell. 2021; 21(1):e13525.
PMID: 34962049
PMC: 8761018.
DOI: 10.1111/acel.13525.
